Products
Lincomycin is commercially available as a drug premix and as a solution for injection in combination preparations as a veterinary drug. It has been approved in many countries since 1978.
Structure and properties
Lincomycin (C18H34N2O6S, Mr = 406.5 g/mol) is the precursor of clindamycin. Lincomycin hydrochloride monohydrate exists as a white crystalline powder that is very soluble in water.
Effects
Lincomycin (ATCvet QJ01FF02) has bacteriostatic properties.
Indications
Bacterial infectious diseases in swine, dogs, and cats.